logo-loader

Codebase Ventures pumps C$105K into UK app Trad3r, plans tour across the pond

Published: 08:43 20 Feb 2020 EST

Person wearing a white shirt and red jacket smiling at a cell phone in his hand
Codebase invested C$105,000 in the app’s parent company, Aerosax Research and Technology Ltd

Codebase Ventures Inc (CSE:CODE) (OTCMKTS:BKLLF) has completed an investment in the UK mobile game app Trad3r. 

The app lets its 4.3 million users trade not only stocks but celebrities, sports teams and Instagram stories, in exchange for rewards from top companies. 

The game has reached 440,000 daily active users, 103,000 daily purchases and 1 billion monthly interactions. 

READ: Codebase Ventures subsidiary tests Ethereum game CryptoKitties on its blockchain network

Codebase invested C$105,000 in the app’s parent company, Aerosax Research and Technology Ltd. The plan is to hit 10 million users by 2021, and the company is kicking off a UK tour in March with stops in Edinburgh, Manchester, Leicester and Bristol to get the ball rolling.

"The Trad3r app has a proven track record attracting users and investment in the UK," CEO George Tsafalas said in a statement. "This is a rapid growth sector and the unique proposition, combining stocks with celebrities, fantasy sports and one's own social network is working to show that Millennials and Gen Z's are seeking new methods of engagement, and we believe our shareholders will benefit greatly through this early stage investment in an innovator like Trad3r."

Ultimately, the app's expansion strategy includes a push into more than 30 countries.

Codebase is a Vancouver-based investment company that targets early-stage sectors with strong upside. It operates Code Cannabis, a cannabis investment vehicle; Pressland, an anti-fake news operation and Arcology, a blockchain company, among others. 

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com 

Follow him on Twitter @andrew_kessel

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

15 hours, 23 minutes ago